Merck KgaA Q1 Profit Dips, Adj. EBITDA Rises; Backs FY17 Sales Growth View

German drug major Merck KgaA reported Thursday lower net profit in its first quarter, while adjusted EBITDA, a key earnings metric, increased with higher sales. For fiscal 2017, the company continues to expect higher sales, while adjusted earnings would be below or above last year.

from RTT - Earnings http://ift.tt/2qz3ahc
via IFTTT